RP

Regeneron Pharmaceuticals Portfolio holdings

AUM $700M
1-Year Est. Return 67.16%
This Quarter Est. Return
1 Year Est. Return
+67.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.49B
AUM Growth
+$251M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$6.2M
2
+$102K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$58.4B
$1.45B 97.6%
4,444,445
NTLA icon
2
Intellia Therapeutics
NTLA
$1.13B
$34.7M 2.34%
3,702,995
ACET icon
3
Adicet Bio
ACET
$101M
$591K 0.04%
968,183
ADVM icon
4
Adverum Biotechnologies
ADVM
$94.2M
$389K 0.03%
180,909
TSVT
5
DELISTED
2seventy bio
TSVT
– –
-1,254,827
BLUE
6
DELISTED
bluebird bio
BLUE
– –
-21,000